- Cell banking outsourcing involves the storage and maintenance of cell lines by third-party service providers to ensure a continuous supply of authenticated and contamination-free cells for research and production purposes.
- The market is witnessing significant expansion due to the rising use of stem cells and cell therapies in personalized medicine, regenerative treatments, and cancer research
- North America dominated the cell banking outsourcing market with the largest revenue share of 41.2% in 2024, driven by the robust presence of biopharmaceutical companies and increasing R&D investments in advanced therapeutics, including cell and gene therapies
- Asia-Pacific region is expected to witness the highest growth rate in the global cell banking outsourcing market, driven by increasing investments in biotechnology, expanding clinical research activities, and the growing presence of cost-effective contract service providers
- The master cell banking segment dominated the market with the largest revenue share of 46.8% in 2024, attributed to its critical role in establishing a single-source, high-quality cell line for large-scale manufacturing. Master cell banks serve as the foundation for all future cell production, ensuring genetic consistency, stability, and regulatory compliance throughout the product lifecycle. Their significance in biopharmaceutical development and regulatory submissions further reinforces their market dominance
